References
- Gunnes P, Reikerås O, Lygren I. Secretin infusion in acute ischemic left ventricular failure: effects on myocardial performance and metabolism in a closed-chest dog model. J Pharm Exp Ther 1986; 239: 915–8
- Gunnes P, Reikerås O. Peripheral distribution of the increased cardiac output by secretin during acute left ventricular failure. J Pharm Exp Ther 1988; 244: 1057–61
- Gunnes P, Smiseth O A, Lygren I, Jorde R. Effects of secretin infusion on myocardial performance and metabolism in the dog. J Cardiovasc Pharm 1985; 7: 1183–7
- Sheridan D J. Assessment of myocardial contractility in man. Cardiovasc Res 1987; 21: 623–4
- Hotvedt R, Platou E S, Koppang E R, Refsum H. Pentobarbital plasma concentrations and cardiac electrophysiology during prolonged pentobarbital infusion anesthesia in dogs. Acta Anesthesiol Scand 1982; 26: 638–42
- Aukland K, Bowe B F, Berliner R W. Measurement of local blood flow with hydrogen gas. Circ Res 1964; 14: 164–87
- Mjøs O D, Kjekshus J K, Lekven J. Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischaemic injury during norepinephrine infusion in dogs. J Clin Invest 1974; 53: 1290–9
- Ho R J. Radiochemical assay of long-chain fatty acids using 63Ni as a tracer. Anal Biochem 1970; 36: 105–13
- Jorpes J E, Mutt V. Secretin and CCK. Secretin, Cholecystokinin, Pancreozymin and Gastrin, J E Jorpes, V Mutt. Springer Verlag, Berlin 1973; 1–176
- McDevitt D G. The assessment of beta-adreno-receptor blocking drugs in man. Br J Clin Pharmac 1977; 4: 413–25
- Weber K T, Janicki W CH, Schorff S, Pearlman E S, Fishman A P. The contractile behaviour of the heart and its functional coupling to the circulation. Progr Cardiovasc Dis 1982; 24: 375–400
- Ilebekk A, Miller M M, Kiil F. Cardiac performance: independent effects of inotropy and preload at high heart rate. Am J Physiol 1979; 236: H568–76
- Barnes G E, Horwitz L D, Bishop V S. Reliability of the maximum derivatives of the left ventricular pressure and internal diameter as indices of the inotropic state of the depressed myocardium. Cardiovasc Res 1979; 13: 652–62
- Maughan W L, Sunagawa K, Burkhoff D, Graves W L, Hunter W C, Sagawa K. Effect of heart rate on the canine end-systolic pressure-volume relationship. Circulation 1985; 72: 654–9
- Gunnes P, Rasmussen K. Haemodynamic effects of pharmacological doses of secretin in patients with impaired left ventricular function. Eur Heart J 1986; 7: 146–9
- Gunnes P, Reikerås O. Distribution of the increased cardiac output secondary to the vasodilating and inotropic effects of secretin. Scand J Clin Lab Invest 1987; 47: 383–8
- Ross G. Cardiovascular effects of secretin. Am J Physiol 1970; 218: 1166–70
- Beijer H JM, Hulstaert P F, Bouwer F AS, Charbon G A. The effect of secretin on peripheral arterial blood flow. Arch Int Pharmacodyn 1979; 240: 269–77
- Robberecht P, De Neef Camus J-C, Waelbroek M, Fontaine J, Christophe J. The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats. Pfluegers Arch 1983; 398: 217–20
- Chiba S. Effect of secretin on pacemaker activity and contractility in the isolated blood-perfused atrium of the dog. Clin Exp Pharmacol Physiol 1976; 3: 167–72
- Robberecht P, De Neef P, Waelbroeck M, Camus J-C, Fontaine J, Christophe J. Secretin-induced changes in the rate, contractility and adenyl cyclase activity in rat heart atria. Pfluegers Arch 1984; 401: 1–5
- Chatelain P, Robberecht P, De Neef P, Deschodt-Lanckman M, Koening W, Christophe J. Secretin and VIP-stimulated adenyl cyclase from rat heart. Pfluegers Arch 1980; 389: 21–7
- Chatelain P, Robberecht P, Camus J-C, et al. The adenyl cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors. Eur J Pharmacology 1983; 93: 271–6
- Farah A E. Glucagon and the circulation. Pharmacological Reviews. 1983; 35: 181–217